Advanced search
Publication Cover
Leukemia & Lymphoma Volume 55, 2014 - Issue 12
Submit an article Journal homepage
476
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia

Stephen P. MulliganDepartment of Haematology, Royal North Shore Hospital, Sydney, AustraliaCorrespondence[email protected]
,
Karin KarlssonDepartment of Hematology, University Hospital, Linköping, Sweden;Department of Hematology, Skåne University Hospital, Lund, Sweden
,
Mats StrömbergDepartment of Oncology, Karolinska University Hospital, Stockholm, Sweden
,
Viggo JønssonDepartment of Hematology, National Hospital, Copenhagen, Denmark
,
Devinder GillDepartment of Haematology, Princess Alexandra Hospital, Brisbane, Australia
,
Jens HammerströmDepartment of Hematology, St Olav University Hospital, Trondheim, Norway
,
Mark HertzbergDepartment of Haematology, Westmead Hospital, Sydney, Australia
,
Roger McLennanDepartment of Haematology, Ballarat Base Hospital, Ballarat, Australia
,
Bertil UgglaDepartment of Medicine, University Hospital Örebro, Sweden
,
John NormanDepartment of Haematology, Royal Adelaide Hospital, Adelaide, Australia
,
Jonas WallvikDepartment of Medicine, Sundsvall, Sweden
,
Gunnel SundströmDepartment of Hematology, Norrlands University Hospital, Umeå, Sweden
,
Hemming JohanssonDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
,
Yvonne BrandbergDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
,
Jan LiliemarkDepartment of Oncology, Karolinska University Hospital, Stockholm, Sweden;Swedish Council on Health Technology Assessment, Stockholm, Sweden
,
Gunnar JuliussonDepartment of Hematology, University Hospital, Linköping, Sweden;Department of Hematology, Skåne University Hospital, Lund, Sweden
& for the Scandinavian and Australasian Leukaemia Lymphoma Groups (Allg) show all
Pages 2769-2777 | Received 17 Nov 2013, Accepted 07 Feb 2014, Published online: 16 Apr 2014

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Liat Vidal, Ronit Gurion, Ron Ram, Pia Raanani, Osnat Bairey, Tadeusz Robak, Anat Gafter-Gvili & Ofer Shpilberg. (2016) Chlorambucil for the treatment of patients with chronic lymphocytic leukemia (CLL) – a systematic review and meta-analysis of randomized trials. Leukemia & Lymphoma 57:9, pages 2047-2057.
Read now

Articles from other publishers (6)

E. Amiri Souri, A. Chenoweth, S. N. Karagiannis & S. Tsoka. (2023) Drug repurposing and prediction of multiple interaction types via graph embedding. BMC Bioinformatics 24:1.
Crossref
Nil Albiol, Miguel Arguello-Tomas & Carol Moreno. (2021) The road to chemotherapy-free treatment in chronic lymphocytic leukaemia. Current Opinion in Oncology 33:6, pages 670-680.
Crossref
Rajshekhar Chakraborty, Laura Cannella, Francesco Cottone & Fabio Efficace. (2020) Quality of patient-reported outcome reporting in randomised controlled trials of haematological malignancies according to international quality standards: a systematic review. The Lancet Haematology 7:12, pages e892-e901.
Crossref
Yingxin Xu, Kyle Fahrbach, Emily Dorman, Simona Baculea, Sarah Côté, Suzy van Sanden & Joris Diels. (2018) Front-line treatment of patients with chronic lymphocytic leukemia: a systematic review and network meta-analysis. Journal of Comparative Effectiveness Research 7:5, pages 421-441.
Crossref
Tadeusz Robak, Jerzy Błoński, Aleksander Bartłomiej Skotnicki, Magdalena Piotrowska, Tomasz Wróbel, Justyna Rybka, Janusz Kłoczko, Łukasz Bołkun, Bożena Katarzyna Budziszewska, Urszula Walczak, Anatoly Uss, Marta Fidecka & Piotr Smolewski. (2018) Rituximab, cladribine, and cyclophosphamide (RCC) induction with rituximab maintenance in chronic lymphocytic leukemia: PALG - CLL4 (ML21283) trial. European Journal of Haematology 100:5, pages 465-474.
Crossref
Simon Frey, Carl R. Blankart & Tom Stargardt. (2016) Economic Burden and Quality-of-Life Effects of Chronic Lymphocytic Leukemia: A Systematic Review of the Literature. PharmacoEconomics 34:5, pages 479-498.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.